Evaluation
of clinical findings of acetaminophen poisoning and factors associated with its
severity in poisoned patients
Hamid Mohammadi Kojidi 1,
Haniye Sadat Fayazi 1,
Amaneh Khalilzadeh 1,
Mir Saeed Attarchi 1 *
1 Razi Clinical Research Development Unit, Guilan University of Medical Sciences, Rasht, Iran
*Corresponding Author: Mir Saeed Attarchi
* Email: msattarchi@yahoo.com
Abstract
Introduction: Acetaminophen poisoning is one of the most common types of suicide in
Iran. Investigation and identification of factors affecting the severity of
this poisoning can have a significant impact on optimal treatment management.
The aim of this study was to evaluate the clinical findings of Acetaminophen
poisoning and its associated factors.
Materials and Methods: In a cross-sectional study, the files of patients
admitted due to acetaminophen poisoning in the years 2011-2015 in the poisoning
ward of Razi Educational Center in Rasht have been reviewed. Demographic
characteristics of the poisoned, acetaminophen use, number of days of
hospitalization, poisoning outcome, history of addiction, previous suicide
history, time spent from drug use to hospitalization, clinical findings,
severity of poisoning and laboratory test results were extracted from patients'
records and registrated. Independent t-test,
chi-square and regression analysis were used to investigate the relationship
between study variables and severity of intoxication.
Results: In this study, 244 cases of poisoning were investigated. The highest
frequency of symptoms was related to nausea (25.9%) and then vomiting (22.1%).
More than 99% of those poisoned recovered. Mean hospital stay
(P = 0.015), mean hospital stay after acetaminophen (P = 0.001) and mean liver
enzyme levels (P < 0.05) were significantly higher in the moderate to severe
intoxication group compared to the asymptomatic group. In the logistic
regression analysis, even after removing confounders, there was a statistically
significant association between the duration of the patient's arrival at the
hospital (P <0.001, OR = 15.44; 95% CI: 5.88- 40.44) and the amount of
acetaminophen consumption (P <0.001, OR = 4.62; 95% CI: 2.00- 10.68) with
severe poisoning.
Conclusion: In this study, most of those poisoned were female and aged 21-30
years. Most of the poisoned recovered. The acetaminophen dose and the duration
of drug intake until hospitalization were significantly associated with the
severity of poisoning and the mean values of liver function tests were higher
in the high poisoning group.
Keywords: Suicide, Poisoning, Acetaminophen, Prognosis
Introduction
Suicide
is a major problem in the world today and the fifth leading cause of death
among people aged 15-49 worldwide. Asian countries account for about 60% of
global suicides (1). The choice of suicide type varies according to
geographical, social and demographic characteristics (2). Poisoning is the most
common type of suicide in Asian countries, accounting for more than 60% of all
deaths. In developing countries, poisoning is more common due to weak
regulations, lack of monitoring systems and easy access to toxic drugs or
chemicals. In Iran, poisoning is the most common cause of hospitalization and
the second leading cause of death (3). Acetaminophen is the most commonly used
antipyretic and analgesic in the world. Due to the easy availability and
widespread use of acetaminophen, drug intoxications from drug use and even drug
abuse have always been a problem (4). In 2005, more than 165,000 cases of
poisoning were reported in the USA, of which about 67,000 were from
acetaminophen alone (5). In the United Kingdom, 50% of poisoning cases resulted
in hospitalization due to acetaminophen poisoning (6). In previous studies,
acetaminophen poisoning was considered one of the most common causes of
poisoning in Iran (7,8). In Iran, acetaminophen is an over-the-counter drug
that comes in different formulations and dosages. Overdose of this drug is
often observed in suicidal behaviour.
Early
manifestations of acetaminophen poisoning are usually mild and non-specific and
include nausea, vomiting, abdominal pain and weakness. These symptoms may
improve within the first 24 hours or lead to progressive liver and kidney
damage. In severe poisoning, patients may experience signs and symptoms of
liver damage, including metabolic acidosis, coagulopathy and hepatic
encephalopathy. Renal damage occurs in less than 2% of poisoned individuals
without hepatotoxicity and in 25% of poisoned individuals with severe
hepatotoxicity (9,10).
In a
cross-sectional and retrospective study, Pajoumand et
al. reviewed the medical records of 185 patients with acetaminophen poisoning
referred to Loghman Hakim Hospital. Demographic
information, laboratory findings, incidence of toxic hepatitis and renal
failure were compared between poisoned and non-poisoned patients. Most of the
poisoned were discharged on the first day and there were no deaths. But three
patients had liver intoxication. The severity of intoxication depended on the
ascetic serum concentration of acetaminophen and the elapsed time after administration
of the drug (11). In a study (12) over a two-year period from January 2005 to
January 2007, 85 patients admitted to Sina Hospital with acute acetaminophen
poisoning were followed up. About 64% of the patients were female. In adults,
acceptance was due to suicidal ideation rather than accidental poisoning.
Patients who took more than 150mg/kg of acetaminophen or had impaired liver
function had a longer hospital stay. There were no deaths in this study. The
timely use of N-acetylcysteine in these poisoners may justify the lack of
mortality. A study (13) of 21 patients who had attempted suicide by overdose of
paracetamol at Maharaj Nakorn Chiang Mai Hospital
between 2002 and 2000 was examined. Most of those poisoned were women (76%),
students (38%) and employees (33%). The average age of those poisoned was 22
years and most cases were single (86%). The number of paracetamol tablets taken
(500 mg tablets) ranged from 10-90 tablets. The blood levels of paracetamol
were 0.12-8.3g/l. Nausea and vomiting were present in all poisoning cases. In
this study, several subjects suffered from liver involvement, but all survived
and recovered completely.
Identifying
the factors that influence the prognosis of this poisoning may be effective in
the management of acetaminophen poisoners. In our studies abroad, a number of
predictors of the course and severity of this poisoning, such as age, early
administration of N-acetylcysteine and arterial lactate levels have been
identified (14,15). However, few studies have been conducted in this field in
Iran, so in this study, we investigated the clinical outcomes and factors
related to the severity of acetaminophen poisoning.
Materials and Methods
Study
Design and Subjects
This
study is a cross-sectional study that examines the records of hospitalised patients due to poisoning from the consumption
of different amounts of acetaminophen with suicidal intent during the years 2011-2015 in the poisoning ward of Razi Educational Center in Rasht. In this
study, as a sample of the study, the records of all patients who were referred
to this hospital and admitted to this center with a diagnosis of acetaminophen
poisoning from the beginning of 2011 to the end of 2015 were examined. All
patient information, especially patient identity information, was kept
confidential and the results of the study were presented in general. All
provisions of the Helsinki Convention were followed in this study. This
research was the dissertation of a medical student (Ameneh
Khalilzadeh Sabet Masouleh) conducted to obtain a degree in general medicine
(registration number: 188951012). This research was approved by the Research
Ethics Committee of Guilan University of Medical Sciences
and the code of ethics obtained from the Vice Chancellor for Research of Guilan University of Medical Sciences is
IR.GUMS.REC.1396.7.
Inclusion
criteria included all patients whose records included the use of acetaminophen.
Patients whose medical records were incomplete or illegible or who had taken
other medications in addition to acetaminophen were excluded from the study. It
is noteworthy that none of the clients complained about taking acetaminophen
due to the increased dose of this drug and all had used this drug with suicidal
intent.
To
conduct this study, a checklist was designed by the researchers and included
patient demographic characteristics (age, sex, occupation, education),
acetaminophen use (number and dose), number of hospitalization days, disease outcome (recovery or death),
history of underlying diseases, history of drug dependence (type of substance
and method of use), history of previous suicide, history of drug use (type and
amount of drug), time interval between drug use and hospitalization , clinical
findings (asymptomatic, headache, abdominal pain, nausea, vomiting, anorexia,
sweating, drowsiness, decreased level of consciousness, seizures, shortness of
breath, etc.), and the results of the laboratory tests and treatment
(administration of activated charcoal and n-acetylcysteine) were extracted from
the patient records and recorded.
Intensity
of the poisoning:
Patients
based on poisoning severity score (PSS) (16) in terms of severity and outcome
into five groups
(0) None: No
symptoms or signs related to poisoning
(1) Minor: Mild, transient and spontaneously resolving symptoms
(2)Moderate: Pronounced or prolonged symptoms
(3) Severe: Severe or life-threatening symptoms
(4) Fatal: Death
Have
been classified.
Statistical
analysis
After
collecting the data by checklist, the information was entered into SPSS
software version 16 and the necessary analyses were carried out. Percentage,
mean and standard deviation were used to express descriptive variables.
The
T-test was used to compare these variables among the groups. The χ2 was used to
compare the qualitative variables. Logistic regression analysis was used to
eliminate the confounding variables and test the correlation between prognostic
factors and severity of poisoning.
In
the regression model, patients were divided into the mild to low intensity
group (group one: None and Minor) and the moderate to severe intensity group
(group two: Moderate, Severe, Fatal) according to the severity of poisoning
using the POISONING SEVERITY SCORE and in the regression model in the form
of these two groups were analysed and compared.
Furthermore,
the patients were divided into two groups according to the toxic dose of
acetaminophen Acetaminophen less than 7.5g and equal
to or greater than 7.5g were classified (17) and compared in a regression
analysis.
P
values less than 0.05 were considered statistically significant. The results of statistical analysis are
expressed as odds ratio (OR) with 95% confidence intervals (95% CI).
Results
In
this study, all 244 cases of medical records in a given period were examined,
of which all poisoned persons had taken acetaminophen to commit suicide. In
terms of gender, 31.1% (76 subjects) were poisoned and 68.9% (168 subjects)
were female. The average age of the subjects was 25.17 (±10.04) years, with the youngest poisoned being 14 years old and
the oldest 80 years old.
The
mean length of hospital stay for the patients studied
was 2.1 (±1.64)
days, with a minimum length of hospital stay of one day and a maximum length of
hospital stay of 22 days. The mean duration of acetaminophen use
until the patient arrived at the hospital and was admitted to the hospital was
4.1 (±4.27)
hours with a range of 30 minutes to 48 hours. 18.6% of patients had an
underlying medical condition, 11.9% had a history of addiction, 12.3% had a
history of suicide and 81.6% had a history of drug use. Of the 244 subjects, 42
(17.2%) had no symptoms and 202 had symptoms. The highest frequency of symptoms
related to nausea (25.9%), followed by vomiting (22.1%), drowsiness (16.9%),
headache (10.4%), abdominal pain (9%) and decreased consciousness (6.7%). The
mean values of the liver function tests, namely AST,
ALT, ALKP, were 23.2, 23.1 and 190.1 U/L, respectively. The mean values of the
kidney tests, namely BUN and Cr, were 10.91 and 0.90 mg/dl, respectively. 93.4%
of patients were prescribed activated charcoal and gastric lavage and 62.3% of
patients were prescribed acetylcysteine. In the end, more than 99% of patients
recovered and only 0.8% of cases ended in death. Patients were divided into two
groups based on the mean time of arrival at the hospital after taking
acetaminophen, such that 86 patients (35.2%) were admitted to the hospital
three hours or less or 158 patients (64.8%) were admitted more than three hours
after taking acetaminophen. Based on the dose of acetaminophen, those poisoned
were divided into two groups with a dose of less than 7.5g (100 people or 41.0%)
or a dose of 7.5 or more (144 people or 59.0%). According to the PSS criteria,
the poisoned persons were divided into 5 groups according to the severity of
poisoning: 42 persons (17.2%) None, 71
persons (29.1%) Minors, 98 persons (40.2%) Moderate, 31 persons (12.7%) Severe
and 2 persons (0.8%) Fatal have been classified. Finally, we classified those poisoned into two groups according to the
severity of the disease. The first group, i.e.
asymptomatic patients to mild symptoms (None to Minors), were 113 (46.3 %) and
the second group, i.e. moderate severity to death (Modarate
to Fatal), were 131 (53.7 %).
Table 1 examines and compares the mean values of
demographic and clinical variables and laboratory test results in the patient
groups by disease severity. As the results from Table 1 show, the mean length
of hospital stay (P = 0.015) and the mean time to hospitalization after acetaminophen ingestion (P =
0.001) were significantly larger number of moderate to death ( Moderate to
Fatal) poisonings occurred than in the group of asymptomatic to mild (None to
Minors) poisonings. The mean values of liver enzymes in the moderate to fatal
intoxication group were higher and this difference was statistically
significant (P < 0.05).
Table 1. Comparison of mean values of
clinical, demographic and laboratory variables by severity of acetaminophen
poisoning.
The significance level |
Severity of the poisoning |
Variable |
|
Moderate to Fatal (Mean - Standard deviation) |
None to Minors |
Clinical and demographic
variables |
|
0.848 |
25.06
(10.14) |
25.30 (9.97) |
Age
(years) |
0.015 |
2.34 (2.02) |
1.83 (0.96) |
Length of hospital stay (days) |
0.001 |
5.13 (5.43) |
2.90 (1.59) |
Duration
of drug use until hospitalization (hours) |
|
|
|
Laboratory variable |
0.575 |
12.49
(1.45) |
12.30 (2.10) |
Hb
(g/dl) |
0.047 |
25.68 (16.11) |
20.13 (13.06) |
AST(U/L) |
0.044 |
26.54
(32.78) |
19.82
(14.15) |
ALT(U/L) |
0.019 |
200.35 (75.94) |
179.07 (62.67) |
ALKP(U/L) |
0.585 |
13.65 (11.46) |
12.85 (10.27) |
BUN
(mg/dl) |
0.344 |
0.96 (1.07) |
0.86 (0.35) |
Cr (mg/dl) |
Table 2 examines the association between the qualitative
variables of the study and the severity of intoxication. As the results of this
table show, there was no statistically significant association between gender,
history of addiction and history of underlying disease with the severity of
intoxication (P > 0.05). However, there was a statistically significant
association between the duration of poisoning from suicide to hospitalization,
the amount of acetaminophen and a history of suicide with the severity of
poisoning (P <0.05). The group of patients who came to the hospital
more than three hours after the suicide with acetaminophen, the group of
patients who received a dose of 7.5g or more of acetaminophen had a suicide
attempt and had a history of suicide, respectively 7, 7 and 2.6 times higher
than the group of patients admitted to hospital 3 or less hours after suicide
with acetaminophen, groups of patients who committed suicide with a dose of
less than 7.5g of acetaminophen and Groups of patients who had attempted
suicide with a dose of less than 7.5g acetaminophen and groups with no history
of suicide had a moderate to fatal risk of poisoning (Table 2).
Table 2. Assessment of the association
between qualitative variables of the study with the severity of acetaminophen
poisoning.
Variable |
Severity of the poisoning |
The significance level |
||
None to Minors (number) |
moderate to fatal (number) |
OR (95%CI) |
||
Acetaminophen
dosage (g) Less
than 7.5 7.5
and higher |
73 40 |
27 104 |
7.03
(3.96-12.46) |
0.0001> |
Duration
of drug use until hospitalization (hours) Three
and less More
than three |
65 48 |
21 110 |
7.09 )3.90-12.89( |
0.0001> |
Gender Male Female |
36 77 |
40 91 |
1.03 )0.77-1.37( |
0.890 |
History
of addiction Yes No |
15 98 |
14 117 |
1.27
)0.58-2.78( |
0.557 |
Suicide
story Yes No |
10 93 |
20 121 |
2.60 )1.16-5.82( |
0.019 |
History
of the underlying disease Yes No |
24 89 |
19 112 |
1.59 )0.81-3.08( |
0.181 |
Liver function test values were assessed according to the
amount of acetaminophen used. The values of AST, ALT and ALKP were
statistically significantly higher in the group consuming 7.5g and more than acetaminophen
than in the group consuming less than 7.5g (P < 0.05) (Table 3).
Table 3. Assessment of the relationship
between the levels of functional liver enzymes in relation to the dose of
acetaminophen.
The significance level |
Acetaminophen dosage (g) |
Liver function test |
|
7.5 and
higher (mean - standard deviation) |
Less than 7.5 (mean -
standard deviation) |
||
0.002 |
25.97 (16.63) |
19.95
(10.81) |
AST(U/L) |
0.023 |
26.59 (30.94) |
18.88 (15.71) |
ALT(U/L) |
0.0001 |
208.83
(73.64) |
164.10
(57.16) |
ALKP(U/L) |
Logistic regression analysis was used to eliminate
confounding factors and examine the more precise association between the
variables of patient arrival time at the hospital and the amount of
acetaminophen consumption with the severity and outcome of the illness (table
4). As the results of this analysis show, even after removing confounding
factors, there is a statistically significant association between the time of
the patient's arrival at the hospital (P <0.001, OR = 15.44; 95% CI:
5.88-40.44) and the amount of acetaminophen ( P
<0.001, OR = 4.62; 95% CI: 2.00- 10.68) with severe poisoning. In this
analysis, no correlation was found between age, sex, history of addiction,
history of suicide and history of underlying disease with the outcome of
poisoning (P> 0.05).
Table 4. Investigation of the association between
factors related to the outcome of poisoning by logistic regression analysis*.
Variable |
Condition |
β |
OR |
95%CI |
P-value |
Fixed coefficient |
--------- |
- 6.50 |
0.
001 |
------------ |
0.0001> |
Acetaminophen dosage (g) |
Less than 7.5 7.5 and higher |
1.53 |
1.00 4.62 |
------------- 2.00 -10.68 |
0.0001> |
Duration
of drug use until hospitalization (hours) |
Three and less More than three |
2.73 |
1.00 15.44 |
-------------- 5.89-40.44 |
0.0001> |
*Intensity and consequence of poisoning: reference group - None to
Minors, comparison group - moderate to fatal.
Discussion
Acetaminophen is one of the most commonly used
drugs in patients with drug intoxication. Acetaminophen is the second most
commonly used drug for self-medication after tricyclic antidepressants (18). In
Iran, acetaminophen is an over-the-counter drug available in several
formulations and in different dosages. Acetaminophen is a dose-dependent
hepatotoxin found in many products on the market and can cause acute liver
damage when taken in doses of more than 6 to 10 grams per day (19). In our
study, 244 patients with acetaminophen poisoning who had attempted suicide were
examined. In the present study, most of the patients were aged 21-30 years and
the mean age of the subjects was 25.17 years. Previous studies have reported
that most acetaminophen poisonings are observed in young and early adulthood,
but most poisonings resulting in death are observed in older age (20). In the
study, the mean age of acetaminophen poisoning patients was 21.81 years and in
both the male and female age groups, the most common age of acetaminophen
poisoning was 20 years (20). A study of 1,019 patients with acetaminophen
poisoning in Denmark from 1994 to 2003 found that age 15 to 24 years was the
most common age for poisoning and that females outnumbered males. However,
deaths from paracetamol poisoning occur more frequently in patients aged 40
years and older (14). Similar to other studies where women were the majority of
acetaminophen poisoners, in our study women were the highest percentage of
patients consuming varying amounts of acetaminophen for suicide and
hospitalization (68.9%). In the study by Zyoud et al,
acetaminophen suicide was higher among women than men in Malaysia, but men used
higher toxic doses of the drug (21). In another study of 1,543 patients with acetaminophen poisoning in Canada
between 1995 and 2004, the prevalence of cases was about three times higher in
those aged 10-29 years than in those over 30 years, and 68% of patients were
women with acetaminophen poisoning (22). Of the 244 people we studied, 202 had
symptoms. Among 202 symptomatic patients, the highest symptom frequency was
associated with nausea (25.9%), vomiting (22.1%), drowsiness (16.9%) and only
0.8% of those poisoned died. During the study by Badsar
et al (8), 31.2% of patients had no significant clinical manifestations. In
other patients, the most common clinical symptom was nausea (50.4 %). After
ingestion of acetaminophen, the drug is rapidly absorbed from the
gastrointestinal tract and reaches therapeutic levels within 30 minutes to 2
hours. Overdose peaks within 4 hours (23). Toxicity of acetaminophen occurs at
a dose of 7.5 to 10 grams per day. The mortality rate due to paracetamol
overdose is currently about 0.4% (24). The toxicity of paracetamol is divided
into four stages (24). The first stage The first 24
hours after consumption: This stage is the most critical stage and is characterised by vague findings such as nausea, weakness,
vomiting and lethargy. Laboratory findings are usually normal. Second stage 24
to 72 hours after use: Initially, the signs and symptoms of the first stage
disappear and patients appear clinically improved, while hepatic
aminotransferases, serum prothrombin time and total bilirubin levels increase
and renal dysfunction may occur. Third stage 72 to 96 hours after consumption:
In this stage, symptoms become more prominent. Systemic findings, including
weakness, nausea and vomiting, reappear and may be associated with central
nervous system involvement such as confusion, drowsiness and possible coma.
Jaundice may occur, as well as damage to the pancreas, kidneys and heart.
Fourth stage 4 days to 2 weeks after consumption (recovery phase): During this
period, liver problems are resolved. In this stage, clinical symptoms disappear
and laboratory values normalise, and permanent damage
rarely occurs. The course of acetaminophen poisoning can range from complete
uncomplicated recovery to sometimes extensive liver necrosis to severe liver
failure with bleeding complications, renal failure, hepatic encephalopathy and
death in the next few days (25). In our study, the laboratory index of liver
enzymes was statistically significant between groups with different severity of
poisoning. Identifying the unfavourable prognostic
markers at the onset of the patient after acetaminophen poisoning is crucial
for assessing the necessary interventions in clinical care. The results of one
study (15) showed that advanced age, higher ALT, bilirubin and lactate levels,
and lower levels of factor V and arterial pH were significantly associated with
a poor prognosis of acetaminophen poisoning. In the study by Taghadosi Nejad and colleagues, careful examination of the
medical history and simultaneous monitoring of plasma levels of acetaminophen
were used to investigate the effective factors in causing severe poisoning in
order to better select treatment priorities with N-acetylcysteine. This study
was conducted in 2007 on 170 patients at Loghman
Hospital who had taken more than 7.5 grams of acetaminophen based on their
clinical history. The average age of those poisoned was 21.81
years, 55.3% were female. The prevalence of poisoning was higher in the third
decade of life. The mean plasma level of the drug was 18.7 μg
/ ml. Variables such as the number of suicide attempts, the number of tablets
taken and the time interval between drug intake and hospitalization had an
influence on the severity of poisoning. In this study, in cases where it was
not possible to quickly determine the plasma level of acetaminophen to
determine the need for N-acetylcysteine, some biographical factors such as
medication overdose, suicidal ideation and delayed hospitalisation
are known risk factors, which can be used in designing the treatment process
(20). In our study, charcoal was prescribed and
gastric lavage was performed in 93.4% of patients and acetylcysteine was
prescribed in 62.3% of patients. The mean value of liver function tests in the
moderate to severe poisoning group was also higher and statistically
significant (P < 0.05). In our study, the mean length of hospital stay (P = 0.015) and mean time to hospitalization after
acetaminophen (P = 0.001) were significantly higher in the moderate-to-severe
poisoning group than in the asymptomatic-to-mild group. Even after adjusting
for confounding factors, there was a statistically significant association
between the duration of the suicide attempt until hospitalization, the amount
of acetaminophen consumed and the suicide history with the severity of
poisoning (P < 0.05). The group of patients who arrived at the hospital more
than three hours after attempting suicide with acetaminophen had a higher risk
of moderate to severe poisoning than those who attempted suicide with a dose of
7.5g or more of acetaminophen. . In our study, the
levels of AST, ALT, ALKP were statistically significantly higher in the group
with 7.5 and more acetaminophen than in the group with less than 7.5g (P
<0.05). In a retrospective cohort study over a 5-year period from 1 January
2004 to 31 December 2008, patients admitted to the emergency department within
24 hours of taking acetaminophen were included in the study. The frequency of
vomiting in these poisoned patients was 65.3% at the time of admission.
Multiple logistic regression analysis showed that there was a significant risk
of vomiting in patients who reported a acetaminophen
dose of 10g or more (p < 0.001) and a delay of more than 8 hours (p =
0.030). The increase in the frequency of vomiting episodes at first
hospitalization appears to be an important indicator of the risk of renal and
hepatic involvement in the near future after acetaminophen poisoning (26). The
strongest predictor of severe hepatotoxicity in patients with acetaminophen
poisoning is delayed treatment with N-acetylcysteine or no antidote in patients
with more than 10 g of paracetamol or with toxic serum levels (27). One study (28) investigated the association between renal function at first
hospitalization and the outcome of severe paracetamol poisoning. In this study,
it was found that creatinine level at first admission predicted poor outcome in
paracetamol overdose.
One of the limitations of our study was the
lack of access to acetaminophen serum levels. The establishment and organisation of advanced laboratories to measure drug
levels, including paracetamol serum levels, is recommended for optimal
treatment of poison poisoners. Also, this study was a cross-sectional study in
which, of course, the statement on the correlation of variables was not
conclusive and it is recommended to conduct a prospective cohort study.
Conclusions
In the present study, acetaminophen poisoning was observed in patients with
suicidal ideation mainly in women and aged 21-30 years. None of our patients
died. Most of them seem to have suicidal thoughts and behaviour
rather than making real efforts to end their lives. However, we recommend that
you take steps to limit the dose of this medicine without a prescription. The
acetaminophen dose and the duration of drug administration until hospitalisation were also associated with the severity of
intoxication, and the mean values of the liver function tests were higher in
the high-severity intoxication group.
Author contribution
HMK, HSF, AKh and MSA
designed the project and wrote the manuscript and alsp
collected the data. All the authors read and confirmed the final edited version
of the manuscript.
Conflict of interest
No potential conflict of interest was reported by the authors.
References
1. Chen Y, Wu
K, Yousuf S, Yip P. Suicide in Asia: opportunities and
challenges.
Epidemiol Rev 2012; 34: 129–44.
2. Fisher L.B, Overholser J.C, Dieter
L. Methods of committing suicide among 2,347 people in Ohio. Death Stud 2015;
39 (1): 39–43.
3. Khodabandeh F, Emamhadi M, Mostafazadeh B. Epidemiological Assessment of acute
poisoning Death– One year Survey. International Journal of Medical Toxicology
and Forensic Medicine 2013; 2: 103-9.
4. Bunchorntavakul C, Reddy KR.
Acetaminophen-related hepatotoxicity. Clinics in liver disease 2013; 17(4):
587-607.
5. American Association of Poison Control
Centers, 2005. Available from: http//www.aapc.org. (Accessed January 7, 2007).
6. Townsend E, Hawton K, Harriss L, Bale E, Bond A. Substances used in deliberate
self-poisoning 1985–1997: trends and associations with age, gender, repetition
and suicide intent. Soc Psychiatry Psychiatr
Epidemiol 2001; 36:228-34.
7.
Ashkani H, Touhidi M, Moeeni SA. A study of suicidal attempts by drugs and
poisonous substances in emergency rooms and intensive care units of hospitals
affiliated with Shiraz University of Medical Sciences. JMR 2002; 1(1):48-54.
8. Zare Fazlohahi
Z, Maleki M, Shaikhi N.
Epidemiology
of Adult poisoning In Talegani
Hospital
of Urmia 1383-1386. Journal
of
Urmia Nursing and Midwifery Faculty
2010; 8:69-74.
9. Green T, Sivilotti M, Langmann C, Yarema M, Juurlink D, Burns M, Johnson
D. When do the aminotransferases rise after acute acetaminophen overdose? Clin Toxicol (Phila) 2010; 48:787-92.
10. Mazer M, Perrone J. Acetaminophen-induced nephrotoxicity:
pathophysiology, clinical
manifestations,
and management. Journal of Medical Toxicology 2008; 4(1):2-6.
11. Pajoumand A, Aliniab
T, Mahdavinejad A, Talaie
H. Puzzling Situation of Acetaminophen Toxicity in a Referral Hospital, Tehran,
Iran. Iranian Journal of Pharmaceutical Sciences 2018: 14 (2): 93-102
12. Noshad H, Sadreddini S, Etemadi
J. Acetaminophen Self-Poisoning: Suicidal and Accidental. Iranian Journal of
Psychiatry and Behavioral Sciences (IJPBS) 2010; 4 (1); 47-52.
13. Narongchai P, Narongchai S.
Paracetamol overdose in suicidal attempt patients. J Med Assoc Thai 2004;87(4):423-6.
14. Schmidt L.E. Age and paracetamol self-poisoning. Gut 2005; 54: 686–90.
15. Castanares-Zapatero D, Dinant V, Ruggiano
I, Willem H, Laterre P.F, Hantson P.
Pattern of Paracetamol Poisoning: Influence on Outcome and Complications.
Toxics 2018; 6: 58.
16. Persson H, Sjöberg G, Haines J, Pronczuk de Garbino J. Poisoning
Severity Score: Grading of acute poisoning. J Toxicology - Clinical Toxicology
1998; 36:205-13.
17. Hodgman MJ,
Garrard AR. A review of acetaminophen poisoning. Crit Care Clin 2012;28 (4):
499-516.
18. Litovitz
TL, Schwartz WK, Rodgers GC, Cobaugh DJ, Youniss J, Omslaer JC, et al.
2001 Annual Report of the American Association of Poison Control Centers Toxic
Exposure Surveillance System. Am J Emerg Med 2002;
20(5): 391-452.
19. Bari K,
Fontana R. J. Acetaminophen Overdose: What Practitioners Need to Know. Clinical
Liver Disease 2014; 4 (1): 17-21.
20. Taghaddosi-nejad F, Ghazi-khansari
A, Hassanian H, Shadnia S, Okazi A, Mehrpour O. Evaluation
of effective variables of medical history for N-Acetyl cysteine prescription in
acetaminophen poisoned patients. J Birjand Univ Med
Sci 2010; 17(3): 198-205.
21. Zyoud SH, Awang R, Sulaiman SA,
Al-Jabi SW. A cross-sectional observation of the
factors associated with deliberate self-poisoning with acetaminophen: impact of
gender differences and psychiatric intervention. Hum Psychopharmacol
2010;25:500–8.
22. Myers RP,
Li B, Fong A, Shaheen AA, Quan H. Hospitalizations for acetaminophen overdose:
a Canadian population-based study from 1995 to 2004. BMC public health 2007; 7:
143.
23. Ye H, Nelson LJ, Gómez Del Moral M, Martínez-Naves E, Cubero FJ.
Dissecting the molecular pathophysiology of drug-induced liver injury. World J
Gastroenterol 2018;24(13):1373-85.
24. Mitchell I,
Bihari D, Chang R, Wendon J, Williams R. Earlier
identification of patients at risk from acetaminophen-induced acute liver
failure. Crit Care Med 1998; 26(2): 279-84.
25. Rumack BH.
Acetaminophen hepatotoxicity: the first 35 years. J Toxicol
Clin Toxicol 2002; 40(1): 3-20.
26. Zyoud S, Awang R, Syed Sulaiman
S.A, Al-Jabi S.W. Assessing the Impact of Vomiting
Episodes on Outcome After Acetaminophen Poisoning. Basic Clin Pharmacol Toxicol 2010;
107(5):887-92.
27. Ayonrinde O, Phelps G, Hurley J, Ayonrinde
O. Paracetamol overdose and hepatotoxicity at a regional Australian hospital: a
4-year experience. Internal medicine journal 2005; 35(11): 655-60.
28. Pakravan N, Simpson K. J, Waring W.S, Bates C.M, Bateman
D.N. Renal injury at first presentation as a predictor for poor outcome in
severe paracetamol poisoning referred to a liver transplant unit. Eur J Clin Pharmacol 2009;
65:163–8.